Humoral Autoimmune Responses to Insulin-Like Growth Factor II mRNA-Binding Proteins IMP1 and p62/IMP2 in Ovarian Cancer

@inproceedings{Liu2014HumoralAR,
  title={Humoral Autoimmune Responses to Insulin-Like Growth Factor II mRNA-Binding Proteins IMP1 and p62/IMP2 in Ovarian Cancer},
  author={Xinxin Liu and Hua Ye and Liuxia Li and Wen Jie Li and Yi Irvette Zhang and Jianying Zhang},
  booktitle={Journal of immunology research},
  year={2014}
}
Ovarian cancer is one of the leading causes of cancer-related deaths among women. There is an urgent need of better approaches for the identification of appropriate biomarkers in the early detection of ovarian cancer. The aim of this study was to elucidate the significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins (IMPs) in patients with ovarian cancer. In this study, autoantibody responses to two members (IMP1 and p62/IMP2) of IMPs were evaluated by enzyme… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 63 references

Cancerassociated autoantibodies toMUC1 andMUC4-A blinded casecontrol study of colorectal cancer in UK collaborative trial of ovarian cancer screening

J. W. Pedersen, A. Gentry-Maharaj, A. Nostdal
International Journal of Cancer, vol. 134, 9, pp. 2180–2188, 2014. • 2014
View 1 Excerpt

Insulin - like growth factor 2 mRNA - binding proteins ( IGF 2 BPs ) : post - transcriptional drivers of cancer progression ?

N. A. Hammer, J. Nielsen
Cellular and Molecular Life Sciences • 2013

Similar Papers

Loading similar papers…